Childhood vaccines lay the foundation for lifelong health, protecting against diseases like measles, mumps, rubella, and ...

The Business Research Company's Farber's Disease Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 Save 30% on all global market reports with code ONLINE30 - stay ...

The Business Research Company's Farber's Disease Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 Save 30% on all global market reports with code ONLINE30 - stay informed ...

Findings from a Phase I trial initiated by Dana-Farber Cancer Institute have demonstrated that the NeoVax personalised cancer ...

Drs Kathryn J. Ruddy and Narjust Florez discuss fertility, pregnancy, sexual health, delays in diagnosis, and the financial burden of young-onset cancer survivorship.

Dana-Farber experts report rising rates of colorectal, pancreatic, esophageal, and other less common GI cancers in people ...

Farber Cancer Institute-initiated phase 1 clinical trial for patients with melanoma show that an updated formula and delivery of the NeoVax personalized cancer vaccine called NeoVaxMI is safe, ...

PJ Branco will ride the 186-mile Pan Mass Challenge route to show support to those experiencing the same battle.

Phase 3 data support “changing the current standard of care to now include neoadjuvant and adjuvant pembrolizumab,” according to Ravindra Uppaluri, MD, PhD.

The hunt for a medical breakthrough has been caught up in the Trump administration's political assault on the university.

Early-onset colorectal cancer cases have surged globally, with incidence rates increasing in 27 of 50 countries or ...

Results of a Dana-Farber Cancer Institute-initiated phase 1 clinical trial for patients with melanoma show that an updated formula and delivery of the NeoVax personalized cancer vaccine called ...